Growth Metrics

Marimed (MRMD) Amortization of Deferred Charges (2020 - 2025)

Marimed has reported Amortization of Deferred Charges over the past 5 years, most recently at $43000.0 for Q4 2025.

  • Quarterly Amortization of Deferred Charges rose 191.49% to $43000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $109000.0 through Dec 2025, up 3533.33% year-over-year, with the annual reading at $73000.0 for FY2025, 29.81% down from the prior year.
  • Amortization of Deferred Charges was $43000.0 for Q4 2025 at Marimed, up from $18000.0 in the prior quarter.
  • Over five years, Amortization of Deferred Charges peaked at $299000.0 in Q2 2023 and troughed at -$301000.0 in Q4 2023.
  • The 4-year median for Amortization of Deferred Charges is $18000.0 (2024), against an average of $24043.5.
  • The largest YoY upside for Amortization of Deferred Charges was 800.0% in 2024 against a maximum downside of 93.98% in 2024.
  • A 4-year view of Amortization of Deferred Charges shows it stood at $176522.0 in 2021, then tumbled by 270.52% to -$301000.0 in 2023, then surged by 84.39% to -$47000.0 in 2024, then surged by 191.49% to $43000.0 in 2025.
  • Per Business Quant, the three most recent readings for MRMD's Amortization of Deferred Charges are $43000.0 (Q4 2025), $18000.0 (Q3 2025), and $18000.0 (Q2 2025).